Effects of deferasirox and deferiprone on cellular iron load in the human hepatoma cell line HepaRG View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2009-12-08

AUTHORS

François Gaboriau, Anne-Marie Leray, Martine Ropert, Lucie Gouffier, Isabelle Cannie, Marie-Bérengère Troadec, Olivier Loréal, Pierre Brissot, Gérard Lescoat

ABSTRACT

Two oral chelators, CP20 (deferiprone) and ICL670 (deferasirox), have been synthesized for the purpose of treating iron overload diseases, especially thalassemias. Given their antiproliferative effects resulting from the essential role played by iron in cell processes, such compounds might also be useful as anticancer agents. In the present study, we tested the impact of these two iron chelators on iron metabolism, in the HepaRG cell line which allowed us to study proliferating and differentiated hepatocytes. ICL670 uptake was greater than the CP20 uptake. The iron depletion induced by ICL670 in differentiated cells increased soluble transferrin receptor expression, decreased intracellular ferritin expression, inhibited 55Fe (III) uptake, and reduced the hepatocyte concentration of the labile iron pool. In contrast, CP20 induced an unexpected slight increase in intracellular ferritin, which was amplified by iron-treated chelator exposure. CP20 also promoted Fe(III) uptake in differentiated HepaRG cells, thus leading to an increase of both the labile pool and storage forms of iron evaluated by calcein fluorescence and Perls staining, respectively. In acellular conditions, compared to CP20, iron removing ability from the calcein-Fe(III) complex was 40 times higher for ICL670. On the whole, biological responses of HepaRG cells to ICL670 treatment were characteristic of expected iron depletion. In contrast, the effects of CP20 suggest the potential involvement of this compound in the iron uptake from the external medium into the hepatocytes from the HepaRG cell line, therefore acting like a siderophore in this cell model. More... »

PAGES

231-245

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s10534-009-9281-9

DOI

http://dx.doi.org/10.1007/s10534-009-9281-9

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1014321744

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/19997770


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1115", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Pharmacology and Pharmaceutical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Benzoates", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Carcinoma, Hepatocellular", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cell Line, Tumor", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Deferasirox", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Deferiprone", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Dose-Response Relationship, Drug", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Ferritins", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hepatocytes", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Iron", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Iron Chelating Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Liver Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Molecular Structure", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Pyridones", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Receptors, Transferrin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Triazoles", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Inserm U991 (EA/MDC), Universit\u00e9 de Rennes 1, H\u00f4pital Pontchaillou, 35033, Rennes Cedex, France", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Inserm U991 (EA/MDC), Universit\u00e9 de Rennes 1, H\u00f4pital Pontchaillou, 35033, Rennes Cedex, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Gaboriau", 
        "givenName": "Fran\u00e7ois", 
        "id": "sg:person.01157767143.75", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01157767143.75"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Inserm U991 (EA/MDC), Universit\u00e9 de Rennes 1, H\u00f4pital Pontchaillou, 35033, Rennes Cedex, France", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Inserm U991 (EA/MDC), Universit\u00e9 de Rennes 1, H\u00f4pital Pontchaillou, 35033, Rennes Cedex, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Leray", 
        "givenName": "Anne-Marie", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Laboratoire de Biochimie G\u00e9n\u00e9rale et Enzymologie, H\u00f4pital Pontchaillou, 35000, Rennes, France", 
          "id": "http://www.grid.ac/institutes/grid.414271.5", 
          "name": [
            "Inserm U991 (EA/MDC), Universit\u00e9 de Rennes 1, H\u00f4pital Pontchaillou, 35033, Rennes Cedex, France", 
            "Laboratoire de Biochimie G\u00e9n\u00e9rale et Enzymologie, H\u00f4pital Pontchaillou, 35000, Rennes, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ropert", 
        "givenName": "Martine", 
        "id": "sg:person.0771434706.05", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0771434706.05"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Inserm U991 (EA/MDC), Universit\u00e9 de Rennes 1, H\u00f4pital Pontchaillou, 35033, Rennes Cedex, France", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Inserm U991 (EA/MDC), Universit\u00e9 de Rennes 1, H\u00f4pital Pontchaillou, 35033, Rennes Cedex, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Gouffier", 
        "givenName": "Lucie", 
        "id": "sg:person.0675373323.25", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0675373323.25"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Inserm U991 (EA/MDC), Universit\u00e9 de Rennes 1, H\u00f4pital Pontchaillou, 35033, Rennes Cedex, France", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Inserm U991 (EA/MDC), Universit\u00e9 de Rennes 1, H\u00f4pital Pontchaillou, 35033, Rennes Cedex, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Cannie", 
        "givenName": "Isabelle", 
        "id": "sg:person.01053640767.94", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01053640767.94"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Inserm U991 (EA/MDC), Universit\u00e9 de Rennes 1, H\u00f4pital Pontchaillou, 35033, Rennes Cedex, France", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Inserm U991 (EA/MDC), Universit\u00e9 de Rennes 1, H\u00f4pital Pontchaillou, 35033, Rennes Cedex, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Troadec", 
        "givenName": "Marie-B\u00e9reng\u00e8re", 
        "id": "sg:person.01310352723.71", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01310352723.71"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Inserm U991 (EA/MDC), Universit\u00e9 de Rennes 1, H\u00f4pital Pontchaillou, 35033, Rennes Cedex, France", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Inserm U991 (EA/MDC), Universit\u00e9 de Rennes 1, H\u00f4pital Pontchaillou, 35033, Rennes Cedex, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lor\u00e9al", 
        "givenName": "Olivier", 
        "id": "sg:person.01067451270.18", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01067451270.18"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Service des Maladies du Foie, H\u00f4pital Pontchaillou, 35000, Rennes, France", 
          "id": "http://www.grid.ac/institutes/grid.414271.5", 
          "name": [
            "Inserm U991 (EA/MDC), Universit\u00e9 de Rennes 1, H\u00f4pital Pontchaillou, 35033, Rennes Cedex, France", 
            "Service des Maladies du Foie, H\u00f4pital Pontchaillou, 35000, Rennes, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Brissot", 
        "givenName": "Pierre", 
        "id": "sg:person.0757107606.24", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0757107606.24"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Inserm U991 (EA/MDC), Universit\u00e9 de Rennes 1, H\u00f4pital Pontchaillou, 35033, Rennes Cedex, France", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Inserm U991 (EA/MDC), Universit\u00e9 de Rennes 1, H\u00f4pital Pontchaillou, 35033, Rennes Cedex, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lescoat", 
        "givenName": "G\u00e9rard", 
        "id": "sg:person.01070673674.33", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01070673674.33"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/978-1-4615-0593-8_3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042970422", 
          "https://doi.org/10.1007/978-1-4615-0593-8_3"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s11095-005-9258-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028776408", 
          "https://doi.org/10.1007/s11095-005-9258-5"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2009-12-08", 
    "datePublishedReg": "2009-12-08", 
    "description": "Two oral chelators, CP20 (deferiprone) and ICL670 (deferasirox), have been synthesized for the purpose of treating iron overload diseases, especially thalassemias. Given their antiproliferative effects resulting from the essential role played by iron in cell processes, such compounds might also be useful as anticancer agents. In the present study, we tested the impact of these two iron chelators on iron metabolism, in the HepaRG cell line which allowed us to study proliferating and differentiated hepatocytes. ICL670 uptake was greater than the CP20 uptake. The iron depletion induced by ICL670 in differentiated cells increased soluble transferrin receptor expression, decreased intracellular ferritin expression, inhibited 55Fe (III) uptake, and reduced the hepatocyte concentration of the labile iron pool. In contrast, CP20 induced an unexpected slight increase in intracellular ferritin, which was amplified by iron-treated chelator exposure. CP20 also promoted Fe(III) uptake in differentiated HepaRG cells, thus leading to an increase of both the labile pool and storage forms of iron evaluated by calcein fluorescence and Perls staining, respectively. In acellular conditions, compared to CP20, iron removing ability from the calcein-Fe(III) complex was 40 times higher for ICL670. On the whole, biological responses of HepaRG cells to ICL670 treatment were characteristic of expected iron depletion. In contrast, the effects of CP20 suggest the potential involvement of this compound in the iron uptake from the external medium into the hepatocytes from the HepaRG cell line, therefore acting like a siderophore in this cell model.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s10534-009-9281-9", 
    "inLanguage": "en", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1102420", 
        "issn": [
          "0966-0844", 
          "1572-8773"
        ], 
        "name": "BioMetals", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "2", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "23"
      }
    ], 
    "keywords": [
      "HepaRG cell line", 
      "HepaRG cells", 
      "effect of deferasirox", 
      "human hepatoma cell line HepaRG", 
      "iron depletion", 
      "cell lines", 
      "transferrin receptor expression", 
      "differentiated HepaRG cells", 
      "oral chelators", 
      "iron overload diseases", 
      "receptor expression", 
      "cell line HepaRG", 
      "cellular iron load", 
      "iron load", 
      "intracellular ferritin", 
      "antiproliferative effects", 
      "labile iron pool", 
      "iron metabolism", 
      "overload diseases", 
      "such compounds", 
      "hepatocyte concentrations", 
      "iron chelators", 
      "ferritin expression", 
      "potential involvement", 
      "anticancer agents", 
      "present study", 
      "ICL670", 
      "iron pool", 
      "cell processes", 
      "calcein fluorescence", 
      "compounds", 
      "hepatocytes", 
      "cell model", 
      "differentiated hepatocytes", 
      "cells", 
      "uptake", 
      "CP20", 
      "iron", 
      "slight increase", 
      "biological responses", 
      "deferasirox", 
      "expression", 
      "acellular conditions", 
      "disease", 
      "chelators", 
      "essential role", 
      "iron uptake", 
      "depletion", 
      "ferritin", 
      "thalassemia", 
      "treatment", 
      "HepaRG", 
      "effect", 
      "exposure", 
      "metabolism", 
      "involvement", 
      "increase", 
      "complexes", 
      "contrast", 
      "storage form", 
      "agents", 
      "fluorescence", 
      "response", 
      "labile pool", 
      "pool", 
      "study", 
      "lines", 
      "role", 
      "external medium", 
      "calcein", 
      "siderophores", 
      "concentration", 
      "purpose", 
      "ability", 
      "medium", 
      "impact", 
      "time", 
      "process", 
      "conditions", 
      "form", 
      "model", 
      "load", 
      "Perl", 
      "ICL670 uptake", 
      "CP20 uptake", 
      "soluble transferrin receptor expression", 
      "intracellular ferritin expression", 
      "unexpected slight increase", 
      "iron-treated chelator exposure", 
      "chelator exposure", 
      "ICL670 treatment", 
      "effects of CP20", 
      "hepatoma cell line HepaRG", 
      "line HepaRG"
    ], 
    "name": "Effects of deferasirox and deferiprone on cellular iron load in the human hepatoma cell line HepaRG", 
    "pagination": "231-245", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1014321744"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s10534-009-9281-9"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "19997770"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s10534-009-9281-9", 
      "https://app.dimensions.ai/details/publication/pub.1014321744"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-01-01T18:21", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220101/entities/gbq_results/article/article_492.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s10534-009-9281-9"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s10534-009-9281-9'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s10534-009-9281-9'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s10534-009-9281-9'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s10534-009-9281-9'


 

This table displays all metadata directly associated to this object as RDF triples.

293 TRIPLES      22 PREDICATES      139 URIs      129 LITERALS      24 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s10534-009-9281-9 schema:about N086607416160469782a8b9c256efa647
2 N16697f79e0cb4cf481342ff19e3cd03a
3 N17a54aedb9374fc78ef875bfa08da4eb
4 N1cafe6ba4a944fd9a902fbfef4eb5aa1
5 N20e08d7dcb8746d7b6ab36f620dc405b
6 N20fe3ebe040d454f81edea5b7c1fcc70
7 N239aefd106914cd789d34f128bf58809
8 N2912ce8cf0bd48dd9098778cc798b91f
9 N3d863592f2c042a8a93f9f345c4fcd4a
10 N4f8036608d264b44a8c520d946d52865
11 N76263476eb58498f9db76a73ffeb3ff8
12 N82befbc553374812961768f92c10b8fc
13 N9e4e438782e14ff785611c1c67aab866
14 Na70a084dee134a5ca06d8c0d6548ca85
15 Ne46712227f0341fb82a233ac5db546dc
16 Ne8d7a6ad4ac845999d3d7240dfbda756
17 Nf25633016e70464dab5f27e44628cd88
18 anzsrc-for:11
19 anzsrc-for:1115
20 schema:author Nbde4874acdbe43c48b1ab7d227e80574
21 schema:citation sg:pub.10.1007/978-1-4615-0593-8_3
22 sg:pub.10.1007/s11095-005-9258-5
23 schema:datePublished 2009-12-08
24 schema:datePublishedReg 2009-12-08
25 schema:description Two oral chelators, CP20 (deferiprone) and ICL670 (deferasirox), have been synthesized for the purpose of treating iron overload diseases, especially thalassemias. Given their antiproliferative effects resulting from the essential role played by iron in cell processes, such compounds might also be useful as anticancer agents. In the present study, we tested the impact of these two iron chelators on iron metabolism, in the HepaRG cell line which allowed us to study proliferating and differentiated hepatocytes. ICL670 uptake was greater than the CP20 uptake. The iron depletion induced by ICL670 in differentiated cells increased soluble transferrin receptor expression, decreased intracellular ferritin expression, inhibited 55Fe (III) uptake, and reduced the hepatocyte concentration of the labile iron pool. In contrast, CP20 induced an unexpected slight increase in intracellular ferritin, which was amplified by iron-treated chelator exposure. CP20 also promoted Fe(III) uptake in differentiated HepaRG cells, thus leading to an increase of both the labile pool and storage forms of iron evaluated by calcein fluorescence and Perls staining, respectively. In acellular conditions, compared to CP20, iron removing ability from the calcein-Fe(III) complex was 40 times higher for ICL670. On the whole, biological responses of HepaRG cells to ICL670 treatment were characteristic of expected iron depletion. In contrast, the effects of CP20 suggest the potential involvement of this compound in the iron uptake from the external medium into the hepatocytes from the HepaRG cell line, therefore acting like a siderophore in this cell model.
26 schema:genre article
27 schema:inLanguage en
28 schema:isAccessibleForFree false
29 schema:isPartOf N57173745128742dba0c50d8591515007
30 Ncbdf89e4f5384ca0918ac5598718013d
31 sg:journal.1102420
32 schema:keywords CP20
33 CP20 uptake
34 HepaRG
35 HepaRG cell line
36 HepaRG cells
37 ICL670
38 ICL670 treatment
39 ICL670 uptake
40 Perl
41 ability
42 acellular conditions
43 agents
44 anticancer agents
45 antiproliferative effects
46 biological responses
47 calcein
48 calcein fluorescence
49 cell line HepaRG
50 cell lines
51 cell model
52 cell processes
53 cells
54 cellular iron load
55 chelator exposure
56 chelators
57 complexes
58 compounds
59 concentration
60 conditions
61 contrast
62 deferasirox
63 depletion
64 differentiated HepaRG cells
65 differentiated hepatocytes
66 disease
67 effect
68 effect of deferasirox
69 effects of CP20
70 essential role
71 exposure
72 expression
73 external medium
74 ferritin
75 ferritin expression
76 fluorescence
77 form
78 hepatocyte concentrations
79 hepatocytes
80 hepatoma cell line HepaRG
81 human hepatoma cell line HepaRG
82 impact
83 increase
84 intracellular ferritin
85 intracellular ferritin expression
86 involvement
87 iron
88 iron chelators
89 iron depletion
90 iron load
91 iron metabolism
92 iron overload diseases
93 iron pool
94 iron uptake
95 iron-treated chelator exposure
96 labile iron pool
97 labile pool
98 line HepaRG
99 lines
100 load
101 medium
102 metabolism
103 model
104 oral chelators
105 overload diseases
106 pool
107 potential involvement
108 present study
109 process
110 purpose
111 receptor expression
112 response
113 role
114 siderophores
115 slight increase
116 soluble transferrin receptor expression
117 storage form
118 study
119 such compounds
120 thalassemia
121 time
122 transferrin receptor expression
123 treatment
124 unexpected slight increase
125 uptake
126 schema:name Effects of deferasirox and deferiprone on cellular iron load in the human hepatoma cell line HepaRG
127 schema:pagination 231-245
128 schema:productId N09144c5373914a8596e18e0fbeae55bc
129 Nc2547a069d2e485090f40d1e445a9e2b
130 Ndbaf989c8a6a496282fd9b1bd5fcc7ba
131 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014321744
132 https://doi.org/10.1007/s10534-009-9281-9
133 schema:sdDatePublished 2022-01-01T18:21
134 schema:sdLicense https://scigraph.springernature.com/explorer/license/
135 schema:sdPublisher N62a9e7bea65d44d79f5fc4cdea6bcb9e
136 schema:url https://doi.org/10.1007/s10534-009-9281-9
137 sgo:license sg:explorer/license/
138 sgo:sdDataset articles
139 rdf:type schema:ScholarlyArticle
140 N086607416160469782a8b9c256efa647 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
141 schema:name Hepatocytes
142 rdf:type schema:DefinedTerm
143 N09144c5373914a8596e18e0fbeae55bc schema:name dimensions_id
144 schema:value pub.1014321744
145 rdf:type schema:PropertyValue
146 N0dd83c1db06e41409532d9416199985f rdf:first Na755f52b12424e768453261cfff68331
147 rdf:rest N21ad9feee1ab4c4faf5b183cfaf430c5
148 N16697f79e0cb4cf481342ff19e3cd03a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
149 schema:name Benzoates
150 rdf:type schema:DefinedTerm
151 N17a54aedb9374fc78ef875bfa08da4eb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
152 schema:name Ferritins
153 rdf:type schema:DefinedTerm
154 N1cafe6ba4a944fd9a902fbfef4eb5aa1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
155 schema:name Receptors, Transferrin
156 rdf:type schema:DefinedTerm
157 N20e08d7dcb8746d7b6ab36f620dc405b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
158 schema:name Triazoles
159 rdf:type schema:DefinedTerm
160 N20fe3ebe040d454f81edea5b7c1fcc70 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
161 schema:name Iron
162 rdf:type schema:DefinedTerm
163 N21ad9feee1ab4c4faf5b183cfaf430c5 rdf:first sg:person.0771434706.05
164 rdf:rest N452fe2748c65401b858899db238cf74f
165 N239aefd106914cd789d34f128bf58809 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
166 schema:name Pyridones
167 rdf:type schema:DefinedTerm
168 N2912ce8cf0bd48dd9098778cc798b91f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
169 schema:name Deferasirox
170 rdf:type schema:DefinedTerm
171 N32ff8f79185148e1b1fd9b214aef199b rdf:first sg:person.0757107606.24
172 rdf:rest N5354a1cf07a641c09514d5b8eb1b1b90
173 N3d863592f2c042a8a93f9f345c4fcd4a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
174 schema:name Iron Chelating Agents
175 rdf:type schema:DefinedTerm
176 N452fe2748c65401b858899db238cf74f rdf:first sg:person.0675373323.25
177 rdf:rest Ndfe7f3bea1824d99839c88e1254497f3
178 N4f8036608d264b44a8c520d946d52865 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
179 schema:name Liver Neoplasms
180 rdf:type schema:DefinedTerm
181 N5354a1cf07a641c09514d5b8eb1b1b90 rdf:first sg:person.01070673674.33
182 rdf:rest rdf:nil
183 N57173745128742dba0c50d8591515007 schema:issueNumber 2
184 rdf:type schema:PublicationIssue
185 N62a9e7bea65d44d79f5fc4cdea6bcb9e schema:name Springer Nature - SN SciGraph project
186 rdf:type schema:Organization
187 N76263476eb58498f9db76a73ffeb3ff8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
188 schema:name Humans
189 rdf:type schema:DefinedTerm
190 N82befbc553374812961768f92c10b8fc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
191 schema:name Deferiprone
192 rdf:type schema:DefinedTerm
193 N9e4e438782e14ff785611c1c67aab866 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
194 schema:name Carcinoma, Hepatocellular
195 rdf:type schema:DefinedTerm
196 Na70a084dee134a5ca06d8c0d6548ca85 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
197 schema:name Female
198 rdf:type schema:DefinedTerm
199 Na755f52b12424e768453261cfff68331 schema:affiliation grid-institutes:None
200 schema:familyName Leray
201 schema:givenName Anne-Marie
202 rdf:type schema:Person
203 Nb76b8f13c3dd4e2c8ac6f62d98c62a5f rdf:first sg:person.01067451270.18
204 rdf:rest N32ff8f79185148e1b1fd9b214aef199b
205 Nbde4874acdbe43c48b1ab7d227e80574 rdf:first sg:person.01157767143.75
206 rdf:rest N0dd83c1db06e41409532d9416199985f
207 Nc2547a069d2e485090f40d1e445a9e2b schema:name pubmed_id
208 schema:value 19997770
209 rdf:type schema:PropertyValue
210 Nc7a91f173d664cf58bb033a6e9ec3f9a rdf:first sg:person.01310352723.71
211 rdf:rest Nb76b8f13c3dd4e2c8ac6f62d98c62a5f
212 Ncbdf89e4f5384ca0918ac5598718013d schema:volumeNumber 23
213 rdf:type schema:PublicationVolume
214 Ndbaf989c8a6a496282fd9b1bd5fcc7ba schema:name doi
215 schema:value 10.1007/s10534-009-9281-9
216 rdf:type schema:PropertyValue
217 Ndfe7f3bea1824d99839c88e1254497f3 rdf:first sg:person.01053640767.94
218 rdf:rest Nc7a91f173d664cf58bb033a6e9ec3f9a
219 Ne46712227f0341fb82a233ac5db546dc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
220 schema:name Molecular Structure
221 rdf:type schema:DefinedTerm
222 Ne8d7a6ad4ac845999d3d7240dfbda756 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
223 schema:name Dose-Response Relationship, Drug
224 rdf:type schema:DefinedTerm
225 Nf25633016e70464dab5f27e44628cd88 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
226 schema:name Cell Line, Tumor
227 rdf:type schema:DefinedTerm
228 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
229 schema:name Medical and Health Sciences
230 rdf:type schema:DefinedTerm
231 anzsrc-for:1115 schema:inDefinedTermSet anzsrc-for:
232 schema:name Pharmacology and Pharmaceutical Sciences
233 rdf:type schema:DefinedTerm
234 sg:journal.1102420 schema:issn 0966-0844
235 1572-8773
236 schema:name BioMetals
237 schema:publisher Springer Nature
238 rdf:type schema:Periodical
239 sg:person.01053640767.94 schema:affiliation grid-institutes:None
240 schema:familyName Cannie
241 schema:givenName Isabelle
242 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01053640767.94
243 rdf:type schema:Person
244 sg:person.01067451270.18 schema:affiliation grid-institutes:None
245 schema:familyName Loréal
246 schema:givenName Olivier
247 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01067451270.18
248 rdf:type schema:Person
249 sg:person.01070673674.33 schema:affiliation grid-institutes:None
250 schema:familyName Lescoat
251 schema:givenName Gérard
252 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01070673674.33
253 rdf:type schema:Person
254 sg:person.01157767143.75 schema:affiliation grid-institutes:None
255 schema:familyName Gaboriau
256 schema:givenName François
257 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01157767143.75
258 rdf:type schema:Person
259 sg:person.01310352723.71 schema:affiliation grid-institutes:None
260 schema:familyName Troadec
261 schema:givenName Marie-Bérengère
262 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01310352723.71
263 rdf:type schema:Person
264 sg:person.0675373323.25 schema:affiliation grid-institutes:None
265 schema:familyName Gouffier
266 schema:givenName Lucie
267 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0675373323.25
268 rdf:type schema:Person
269 sg:person.0757107606.24 schema:affiliation grid-institutes:grid.414271.5
270 schema:familyName Brissot
271 schema:givenName Pierre
272 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0757107606.24
273 rdf:type schema:Person
274 sg:person.0771434706.05 schema:affiliation grid-institutes:grid.414271.5
275 schema:familyName Ropert
276 schema:givenName Martine
277 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0771434706.05
278 rdf:type schema:Person
279 sg:pub.10.1007/978-1-4615-0593-8_3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042970422
280 https://doi.org/10.1007/978-1-4615-0593-8_3
281 rdf:type schema:CreativeWork
282 sg:pub.10.1007/s11095-005-9258-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028776408
283 https://doi.org/10.1007/s11095-005-9258-5
284 rdf:type schema:CreativeWork
285 grid-institutes:None schema:alternateName Inserm U991 (EA/MDC), Université de Rennes 1, Hôpital Pontchaillou, 35033, Rennes Cedex, France
286 schema:name Inserm U991 (EA/MDC), Université de Rennes 1, Hôpital Pontchaillou, 35033, Rennes Cedex, France
287 rdf:type schema:Organization
288 grid-institutes:grid.414271.5 schema:alternateName Laboratoire de Biochimie Générale et Enzymologie, Hôpital Pontchaillou, 35000, Rennes, France
289 Service des Maladies du Foie, Hôpital Pontchaillou, 35000, Rennes, France
290 schema:name Inserm U991 (EA/MDC), Université de Rennes 1, Hôpital Pontchaillou, 35033, Rennes Cedex, France
291 Laboratoire de Biochimie Générale et Enzymologie, Hôpital Pontchaillou, 35000, Rennes, France
292 Service des Maladies du Foie, Hôpital Pontchaillou, 35000, Rennes, France
293 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...